Cargando…
Guidance for pediatric use in prescription information for novel medicinal products in the EU and the US
Pediatric legislations in the European Union (EU) and the United States (US) have increased medicines approved for use in the pediatric population. Despite many similarities between these frameworks, the EU Paediatric Regulation more often provides regulators with a mandate to require pediatric drug...
Autores principales: | Christiansen, Helle, De Bruin, Marie L., Frokjaer, Sven, Hallgreen, Christine E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979467/ https://www.ncbi.nlm.nih.gov/pubmed/35377911 http://dx.doi.org/10.1371/journal.pone.0266353 |
Ejemplares similares
-
Mandatory requirements for pediatric drug development in the EU and the US for novel drugs—A comparative study
por: Christiansen, Helle, et al.
Publicado: (2022) -
Status of Planned and Ongoing Paediatric Trials Investigating COVID-19 Vaccines: A Cross-Sectional Study of Paediatric Clinical Trials Planned in Agreed PIPs and/or Registered in Clinical Trial Databases
por: Christiansen, Helle, et al.
Publicado: (2022) -
Exercise as medicine: Providing practitioner guidance on exercise prescription
por: Kyei-Frimpong, Jamie, et al.
Publicado: (2021) -
Review of Drug Development Guidance to Treat Chronic Obstructive Pulmonary Disease: US and EU Perspectives
por: van Haarst, Aernout, et al.
Publicado: (2019) -
Improving Interactions Between Health Technology Assessment Bodies and Regulatory Agencies: A Systematic Review and Cross-Sectional Survey on Processes, Progress, Outcomes, and Challenges
por: Ofori-Asenso, Richard, et al.
Publicado: (2020)